[144] Aeva Technologies, Inc. Warrants SEC Filing

Rhea-AI Filing Summary

Aeva Technologies, Inc. (AEVAW) Form 144 discloses a proposed sale of 200,000 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $2,756,000. The filing lists 56,327,698 shares outstanding and records the 200,000 shares as founders' shares acquired on 12/05/2016.

The notice also reports recent sales in 2025: 69,901 shares sold on 07/07/2025 for $2,134,077.53 by Soroush Salehian Dardashti, and 250,000 shares sold on 05/19/2025 under a 10b5-1 plan for $3,924,650. The filer affirms no material nonpublic information and references Rule 10b5-1 procedures.

Positive

• Transparent disclosure of a proposed sale of 200,000 common shares through Morgan Stanley Smith Barney LLC, including acquisition details (founders' shares).

Negative

• Insider disposition planned: proposed sale of 200,000 common shares is recorded against 56,327,698 shares outstanding.
• Recent insider liquidity in 2025 includes sales of 250,000 shares (10b5-1, gross proceeds $3,924,650) and 69,901 shares (gross proceeds $2,134,077.53), all disclosed in the filing.

Insights

Securities Analyst

Founder intends to sell 200,000 common shares; prior 250,000 and 69,901-share sales occurred in 2025.

The Form 144 specifies a proposed disposition of 200,000 common shares via Morgan Stanley Smith Barney LLC with aggregate market value $2,756,000. The filing shows these are founders' shares acquired on 12/05/2016 and confirms 56,327,698 shares outstanding. Recent reported dispositions in 2025 include a 250,000 share 10b5-1 sale and a 69,901 share sale, both disclosed with gross proceeds. For investors, this is a factual record of insider liquidity rather than new operating information.

Corporate Governance Expert

Rule 144 notice and 10b5-1 reference show ongoing insider liquidity with explicit transaction details and broker disclosure.

The filing provides concrete compliance elements: broker identification (Morgan Stanley Smith Barney LLC), acquisition history (founders' shares dated 12/05/2016), and prior sales including a 10b5-1 plan. The signer represents no undisclosed material adverse information. These disclosures meet Rule 144 reporting expectations and document insider disposals; they do not by themselves indicate corporate governance changes.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	200000	2756000.00	56327698	08/13/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/05/2016	Founders Shares	Issuer			200000	12/05/2016	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Soroush Salehian Dardashti 555 Ellis Street Mountain View CA 94043	Common	07/07/2025	69901	2134077.53
10b5-1 Sales for SOROUSH SALEHIAN DARDASHTI TTEESS TRUST U/A DTD 10/31/2021 555 Ellis Street Mountain View CA 94043	Common	05/19/2025	250000	3924650.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the AEVAW Form 144 disclose?

The filing discloses a proposed sale of 200,000 common shares via Morgan Stanley Smith Barney LLC with an aggregate market value of $2,756,000.

Who is identified as having sold AEVAW shares in the filing?

The filing lists prior sales by Soroush Salehian Dardashti (69,901 shares on 07/07/2025) and a 10b5-1 trust (250,000 shares on 05/19/2025). The current prospective seller name is not explicitly shown in the header information provided.

How many shares are outstanding and how many are proposed to be sold?

The filing shows 56,327,698 shares outstanding and a proposed sale of 200,000 common shares.

What prior insider sales in 2025 are disclosed?

Two prior transactions are disclosed: 250,000 shares sold on 05/19/2025 under a 10b5-1 plan (gross proceeds $3,924,650), and 69,901 shares sold on 07/07/2025 by Soroush Salehian Dardashti (gross proceeds $2,134,077.53).

Does the filing reference Rule 10b5-1 or attest to material information?

Yes. The filing references a 10b5-1 sale and contains the filer’s representation that they do not know any undisclosed material adverse information; it also notes the date of any 10b5-1 plan when applicable.